ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,938, issued on Sept. 23, was assigned to Propanc Pty Ltd (Camberwell, Australia).
"Proenzyme composition" was invented by Julian Kenyon (Camberwell, Australia) and Ralf Brandt (Camberwell, Australia).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compositions, methods, uses and kits for treating cancer. In particular, the invention relates to compositions and methods of treating cancer in a subject comprising administering chymotrypsinogen in certain amounts, for example greater than about 0.1 mg/kg, and trypsinogen in an amount, for example, greater than about 0.02 mg/kg, thereby treating cancer. The invention also ...